LGND
−$339.7K
1,804 sh @ $188
LGND
LIGAND PHARMACEUTICALS INC
SEC CIK 886163
$255.54
+28.8% · 90 days
90-day buys
$0
0 open-market
90-day sells
$6.57M
39 open-market
Net insider flow
−$6.57M
Net selling
Filings shown
145
Most recent
Advertisement
At a glance
Over the last 90 days, insiders at LGND have sold a net $6.57M of stock (0 open-market buys vs 39 sells).
Largest recent trade: Aryeh Jason sold $1.13M of LGND, trimming their stake 4%.
Most active filer: Kozarich John W, with 44 transactions among the recent filings shown.
Insider transaction history
Form 4 filings for LGND, newest firstLGND
−$17.8K
92 sh @ $194
LGND
−$34.9K
179 sh @ $195
LGND
−$9.2K
47 sh @ $196
LGND
−$18.2K
92 sh @ $198
Advertisement
LGND
−$4.6K
23 sh @ $199
LGND
−$6K
30 sh @ $200
LGND
−$730.6K
3,556 sh @ $205
LGND
−$619.4K
3,015 sh @ $205
LGND
−$440.7K
2,145 sh @ $205
LGND
−$417.9K
2,034 sh @ $205
LGND
−$15.9K
84 sh @ $189
LGND
−$9.3K
49 sh @ $190
LGND
−$39.6K
207 sh @ $191
LGND
−$24.4K
127 sh @ $192
LGND
−$4.3K
24 sh @ $178
LGND
−$35K
196 sh @ $178
LGND
−$27.9K
155 sh @ $180
LGND
−$16.7K
92 sh @ $181
LGND
Davis Todd C, LGND's CEO, spent $175.7K of their own money on 1,680 shares at $105, growing their stake 1%.
+$175.7K
1,680 sh @ $105
LGND
Davis Todd C, LGND's CEO, spent $241.1K of their own money on 2,307 shares at $105, growing their stake 2%.
+$241.1K
2,307 sh @ $105
LGND
Davis Todd C, LGND's CEO, spent $583.6K of their own money on 5,523 shares at $106, growing their stake 4%.
+$583.6K
5,523 sh @ $106
LGND
Davis Todd C, LGND's CEO, spent $243.5K of their own money on 2,500 shares at $97, growing their stake 2%.
+$243.5K
2,500 sh @ $97
LGND
Davis Todd C, LGND's CEO, spent $237.5K of their own money on 4,000 shares at $59, growing their stake 6%.
+$237.5K
4,000 sh @ $59
LGND
−$1.08M
5,083 sh @ $213
Advertisement
About LGND insider activity
This page tracks every recent Form 4 filed for LIGAND PHARMACEUTICALS INC with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.
The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.
Frequently asked questions
How often is LGND insider data updated?
Continuously. We read from SEC EDGAR, so new Form 4 filings for LIGAND PHARMACEUTICALS INC usually appear here within minutes of being accepted by the SEC.
What does "net insider flow" mean?
It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.
Why do some rows show grants or option exercises instead of buys?
Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.
Is this investment advice?
No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.